
Nicotinamide Riboside Shows Promise in Treating Werner Syndrome
A groundbreaking clinical trial demonstrated that nicotinamide riboside (NR), a supplement that boosts NAD+ levels, significantly improved health markers in Werner syndrome patients, including skin ulcers, arterial stiffness, and kidney function, offering new hope for this rare aging disorder and insights into aging processes.
